BlackRock Inc. acquired more than 10.9 million shares of Natera during the second quarter. The stake is valued at approximately $2.96 billion. This investment grants BlackRock a 7.62% ownership stake in the medical research firm.
The disclosure follows Natera’s August 6 earnings report which surpassed market expectations. The company generated $752.75 million in quarterly revenue. This represents a 37.7% increase compared to the previous year. Natera reported a loss of $0.47 per share, which was smaller than analysts expected.
Other major institutions also entered the stock during the second quarter. Deutsche Bank AG and Mitsubishi UFJ Asset Management both initiated new positions in the company.